期刊文献+

探讨白细胞减少症患者T淋巴细胞亚群等六项指标分布特征

The distribution of six indicators including lymphocyte subsets in white blood cell reduction patients
原文传递
导出
摘要 目的调查了解白细胞减少症患者淋巴细胞亚群等6项指标的分布特征与临床意义。方法选择2013年1月至2014年12月期间在同济大学附属第十人民医院住院治疗的白细胞减少症患者103例(外周血WBC计数均<4.0×10~9/L),按骨髓穿刺的粒系增生活跃与否分为骨髓粒系增生欠活跃组(阳性组23例)和骨髓粒系增生活跃组(阴性组80例)。回顾性分析两组白细胞减少症患者中的C反应蛋白(C reactive protein,CRP)、乳酸脱氢酶(lactate de hydrogenase,LDH)、血清总补体活性(complement Hemolytic activity,CH50)、补体C3(complement 3,C3)、红细胞沉降率(erythrocyte sedimentation rate,ESR)、淋巴细胞亚群百分比等指标的差异与分布特征;及评价其对骨髓穿刺辅助诊断白细胞减少症原因的效能。结果 T淋巴细胞、辅助性T淋巴细胞和自然杀伤细胞(natural killer cell,NK)在阳性组分别为(62.42±3.21)%、(21.39±2.39)%、(22.94±1.81)%,阴性组分别为(72.00±3.97)%、(29.73±4.02)%、(11.32±0.38)%,两组差异有统计学意义(t值分别为3.791、3.268、8.658,前两项P值均<0.05,后一项P<0.001)。阳性组的CRP(P_(50)=14.70)高于阴性组(P_(50)=4.25,U=7.008,P=0.03)。结论白细胞减少症骨髓粒系增生欠活跃患者中T淋巴细胞和辅助性T淋巴细胞比例降低、NK细胞比例升高,CRP表达增高,对辅助判断白细胞减少症患者骨髓穿刺粒系增生欠活跃有参考价值。 Objective To evaluate the distribution and clinical significance of 6 indicators including lymphocyte subsets in patients with white blood cell reduction. Methods One hundred and three patients with white blood cells reduction who were diagnosed between January 2013 and December 2014 were divided into two groups according to the results of bone marrow examination(hyperplasia degree of granulocyte system). Methods to retrospective analyze the characters of C reactive protein(CRP), lactate dehydrogenase(LDH), 50% complement hemolysis(CH50), complement C3(C3), erythrocyte sedimentation rate(ESR) and lymphocyte subsets between two white blood cell reduction groups, and to evaluate their effectiveness on bone marrow biopsy for white blood cell reduction diagnosis. Results T lymphocytes, T helper lymphocytes and natural killer(NK) cells in the bone marrow examination positive groups [(62.42 ±3.21) %,(21.39 ±2.39) %,(22.94 ± 1.81) %] and negative groups [(72.00 ±3.97) %,(29.73 ± 4.02) %,(11.32 ± 0.38) %],results were statistically significant differences(t=3.791, 3.268, 8.658. P0.05 or P0.001). CRP in bone marrow puncture positive group(P_(50)=14.70) was higher than negative group(P_(50)=4.25, U=7.008, P=0.03). Conclusions Results show reduction of T lymphocytes and T helper lymphocytes, increase of NK cells and high expression of CRP in white blood cell reduction patients with less active marrow myeloid hyperplasia, which has reference value for auxiliary judging white blood cell reduction patients with less active marrow myeloid hyperplasia.
出处 《中华临床实验室管理电子杂志》 2015年第2期122-125,共4页 Chinese Journal of Clinical Laboratory Management(Electronic Edition)
关键词 淋巴细胞亚群 C反应蛋白 Lymphocyte subsets C reactive protein
  • 相关文献

参考文献11

  • 1Kaushansky, Lichtman, Beutler. Williams Hematology[M]. New York:The McGraw-Hill Companies, 2010:869-875.
  • 2许文荣,王建中,等.临床血液学检验[M].第5版.北京:人民卫生出版社,2012:232.
  • 3Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis[J]. Expert Opin Drug Metab Toxicol, 2015,11(2): 243-257.
  • 4Ng W, Kennar R, Uetrecht J. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-inducedagranulocytosis[J]. Chem Res Toxicol, 2014,27(7): 1104-1108.
  • 5H61sken O, Miller M, Cerwenka A. Exploiting natural killer cells for therapy of melanoma[J]. J Dtsch Dermatol Ges, 2015,13(1):23-29.
  • 6Mahmood S, Upreti D, Sow I, et al. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: eurrent and future perspective[J]. Immunotherapy, 2015,7(3):301-308.
  • 7Motoori M, Yano M, Yasuda T, et al. Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancer[J]. Oncology, 2012,83(2):91-100.
  • 8邹莉玲,余小金,闵捷,沈其君.ROC曲线在医学诊断中的应用与进展[J].东南大学学报(医学版),2003,22(1):67-70. 被引量:46
  • 9简序,王金和,程佩兰.C反应蛋白的临床研究进展[J].国际检验医学杂志,2004,26(5):471-473. 被引量:137
  • 10Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms[J]. Chest, 2013,143(3) 798-807.

二级参考文献13

  • 1李康,林一帆.评价判别模型诊断效果的ROC分析[J].中国卫生统计,1996,13(3):9-12. 被引量:22
  • 2Ridker PM,Hennekens CH,Burring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[].The New England Journal of Medicine.2000
  • 3Feldman JG,Goldwasser P,Holman S,et al.C-reactive protein is an independent predictor of mortality in women with HIV-1infection[].JAIDS Journal of Acquired Immune Deficiency Syndromes.2003
  • 4Melbye H,Bjorkheim MK,Leinan T.Daily reduction in C-reactive pro-tein values,symptoms,signs and temperature in group-A streptococcal pharyngitis treated with antibiotics[].Scandinavian Journal of Clinical and Laboratory Investigation.2002
  • 5Cushman M,Legault C,Barrett-Connor E,et al.Effect of postmenopausal hormones on inflammation-sensitive -proteins: the Postmenopausel Estrogen/Progestin Interventions(PEPI)Study[].Circulation.1999
  • 6Ridker PM,Hennekens CH,Rifai N,et al.Hormone replacement therapy and increased plasma concentration of C-reactive protein[].Circulation.1999
  • 7Bickel C,Rupprecht HJ,Blankenberg S,et al.Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therpy to long-term mortality in patients with anginographically proven coronary artery disease[].The American Journal of Cardiology.2002
  • 8Biasucci LM,Liuzzo G,Grillo RL,et al.Eleavated levels of Creactive protein at discharge in patients with unsatable angina predict recurrent instability[].Circulation.1999
  • 9Bhagat S,Gaiha M,Sharma VK,et al.A comparative evaluation of C-reactive protein as a short -term prognostic marker in severe unstable angina-a preliminary study[].Journal of the Association of Physicians of India.2003
  • 10Sung HJ,Kim JH,Park R,et al.Evaluation of Denka-Seiken turbidimetric high -sensitivity C-reactive protein assay[].Clinical Chemistry and Laboratory Medicine.2002

共引文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部